Judge rejects Trump administration challenge to New York’s ‘Green Light Law’ ...

Ultragenyx Pharmaceutical said on Monday that late-stage studies showed its drug for a type of genetic bone disease failed to ...

I wasted so much time and money at the gym. This year, I cancelled my membership and took control of my health ...

Ultragenyx Pharmaceutical said on Monday that its ‍experimental drug for a type of genetic bone disease did not meet the main goal ‌in late-stage ‌studies. The company was testing the treatment called ...

At the time, we simply accepted this as 'old age'. Today, we understand that one of the major culprits behind this dramatic ...

The 21st century may have blessed us with great tools to track our progress, but the fear of weighing scales is still ...

Dr Akbar Niazi Teaching Hospital (ANTH), in collaboration with the Lions Clubs of Rawalpindi–Islamabad and Bardasht, Pakistan, ...

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (ORBIT) or bisphosphonates (COSMIC) ...

Recent research highlights that for fertility and aging, the egg may be the leading lady, but she needs her supporting cast.

Preventive healthcare saves lives. Early detection of silent issues (high blood pressure, type 2 diabetes, etc.) helps reduce ...

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates (Cosmic) Both studies achieved the secondary endpoint of im ...